Healthtech Startups

BioAtla develops novel monoclonal antibody and cell-based therapeutics for cancer treatment using proprietary platforms including Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!). The company aims to create biologics with improved selectivity for tumor tissue and enhanced therapeutic index.

3 investors

Biobeat develops a cuff-less, ambulatory blood pressure monitoring system built around a proprietary PPG sensor and a platform for tracking vital signs, aimed at helping physicians diagnose and manage hypertension. The FDA-cleared wearable solution serves healthcare providers and their patients in the healthcare/medical device sector.

3 investors

3 investors

Biocollabs offers the Alcohol Belly Protocol, a plant-based liquid supplement designed to support liver function and reduce visceral fat accumulation in people who consume alcohol. The product targets metabolic health and weight loss through improved liver enzyme activity and fat metabolism.

3 investors

Biofidelity develops decentralized biomarker testing solutions, starting with Aspyre Lung Reagents for analyzing DNA and RNA variants in lung cancer research. The company enables genomic testing on existing qPCR platforms globally, avoiding the cost and complexity of next-generation sequencing.

3 investors

BioGeneration Ventures (BGV) is the early-stage arm of the Forbion-BGV platform of funds, investing in and supporting biotech and life sciences companies across their stages of development. It partners with academic institutions, healthcare and pharma companies, and other venture investors across the Netherlands, EU and US.

3 investors

BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.

3 investors

Tenzr Health provides a patient engagement and monitoring platform for physical and occupational therapy recovery. The platform enables care teams to track patient progress outside scheduled visits through guided exercises, education, and symptom tracking while capturing continuous recovery data.

3 investors

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

3 investors

BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.

3 investors

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.

3 investors

BioBrace develops a reinforced bioinductive implant combining collagen scaffolds with PLLA microfilaments to support soft tissue repair, particularly for tendon healing procedures. The product serves orthopedic surgeons and is designed for open or arthroscopic surgical applications.

3 investors

biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease. It applies gene embedding analysis to drug discovery, rescue, and repositioning, with active and planned clinical trials across a range of rare and severe indications.

3 investors

BioT provides cloud infrastructure for medical device companies to enable direct patient engagement and remote care delivery. The platform powers over 100,000 devices for leading medical device manufacturers globally.

3 investors

BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.

3 investors

Bioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures. The company serves healthcare providers and patients seeking clinically effective, cost-efficient alternatives to traditional treatments.

3 investors

Birdie builds integrated software for homecare agencies to manage care operations, patient information, and team coordination. The platform serves home health and social care providers in the UK, combining care management, rostering, analytics, and financial tools.

3 investors

Blip sells FDA-approved nicotine replacement products via direct-to-consumer subscription, with discounts for recurring orders.

3 investors

Bloomwell provides evidence-based Applied Behavior Analysis (ABA) therapy for children with developmental and behavioral challenges. It uses small therapist caseloads to deliver individualized care in a supportive setting.

3 investors

Blume creates functional superfood wellness products designed to celebrate all bodies and support individual wellness journeys. The company combines nutrient-dense ingredients with accessible tastes, emphasizing kindness toward people and environmental sustainability.

3 investors

Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity. Its pipeline focuses on antibody-controlled cytokines for cancer treatment, with potential applications in autoimmune disease, metabolic disorders, and pain management.

3 investors

Pinch provides in-home aesthetic and cosmetic treatments delivered by clinically trained Nurse Practitioners, offering personalized care that comes to the client's location. It serves individuals seeking convenient, on-demand medical aesthetic services scheduled around their own time.

3 investors

BorderPlus sources nursing talent from India and places them with healthcare institutions in Germany, the Gulf Cooperation Council countries, and other markets. The company operates finishing schools in India, Brazil, and the Philippines, combining language training with AI tools for clinical documentation and workforce management.

3 investors

The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan. The solution aims to overcome patient resistance to traditional colonoscopy screening by offering a high-accuracy examination without laxative preparation.

3 investors